公开(公告)号：WO2023048756A1

公开(公告)日：2023-03-30

申请号：PCT/US2022/012818

申请日：2022-01-18

Applicant: ALVAREZ, Francisco Javier

Inventor： ALVAREZ, Francisco Javier

IPC: E04B1/32 ,  E04B1/342 ,  E04C3/02 ,  E04C3/11 ,  E04C3/40

Abstract: An arch building structure includes a plurality of structural arch assemblies, a plurality of purlins, and a plurality of flat roofing sections. The plurality of structural arch assemblies is positioned parallel and offset from each other upon the length of the building. The plurality of purlins is positioned perpendicular to the plurality of structural arch assemblies and radially positioned on the vertexes of the plurality of structural arch assemblies to further strengthen the building. Each of the plurality of flat roofing sections is mounted across a corresponding pair of adjacent purlins from the plurality of purlins so that the building roof can be completed.

公开(公告)号：WO2012071535A3

公开(公告)日：2012-05-31

申请号：PCT/US2011/062085

申请日：2011-11-23

Applicant: AMGEN INC ,  BI, Mingda ,  ALVAREZ-NUNEZ, Fernando ,  ALVAREZ, Francisco Javier

Inventor： BI, Mingda ,  ALVAREZ-NUNEZ, Fernando ,  ALVAREZ, Francisco Javier

IPC: A61K9/14 ,  A61K9/00 ,  A61P5/18

Abstract: The present invention is directed to pediatric formulation of ( R )- N -[-1-(1-naphthyl)-ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride (hereinafter referred to as Cinacalcet HC1) and method of administering the same.

公开(公告)号：WO2012071535A2

公开(公告)日：2012-05-31

申请号：PCT/US2011062085

申请日：2011-11-23

Applicant: AMGEN INC ,  BI MINGDA ,  ALVAREZ-NUNEZ FERNANDO ,  ALVAREZ FRANCISCO JAVIER

Inventor： BI MINGDA ,  ALVAREZ-NUNEZ FERNANDO ,  ALVAREZ FRANCISCO JAVIER

IPC: A61K9/14 ,  A61K9/00 ,  A61P5/18

CPC classification number: A61K9/14 ,  A61K9/0095 ,  A61K9/143 ,  A61K9/146 ,  A61K31/137 ,  A61K47/02 ,  A61K2300/00

Abstract: The present invention is directed to pediatric formulation of (R)-N-[-1-(1-naphthyl)-ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride (hereinafter referred to as Cinacalcet HC1) and method of administering the same.

Abstract translation: 本发明涉及（R）-N - [1-（1-萘基） - 乙基] -3- [3-（三氟甲基）苯基]丙-1-胺盐酸盐（以下称为西那卡塞 HC1）及其施用方法。